These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24081386)

  • 1. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 2. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of home testing of international normalized ratio on clinical events.
    Matchar DB; Jacobson A; Dolor R; Edson R; Uyeda L; Phibbs CS; Vertrees JE; Shih MC; Holodniy M; Lavori P;
    N Engl J Med; 2010 Oct; 363(17):1608-20. PubMed ID: 20961244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial gives nod to home warfarin monitoring.
    Harv Heart Lett; 2009 Feb; 19(6):6. PubMed ID: 19579310
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
    Lane D; Lip GY
    Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home monitoring of warfarin effects.
    Lippi G; Franchini M
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268733
    [No Abstract]   [Full Text] [Related]  

  • 10. Home monitoring of warfarin effects.
    Arellano-Rodrigo E
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268734
    [No Abstract]   [Full Text] [Related]  

  • 11. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
    Schulman S
    N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
    [No Abstract]   [Full Text] [Related]  

  • 13. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 14. [Warfarin treatment in atrial fibrillation].
    Meland E
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2409; author reply 2409-10. PubMed ID: 16998561
    [No Abstract]   [Full Text] [Related]  

  • 15. ARISTOTLE expands the list of novel anticoagulants for thromboprophylaxis in atrial fibrillation.
    Tzeis S; Andrikopoulos G
    Angiology; 2012 Oct; 63(7):558-9. PubMed ID: 22669951
    [No Abstract]   [Full Text] [Related]  

  • 16. Mental illness and warfarin use in atrial fibrillation.
    Walker GA; Heidenreich PA; Phibbs CS; Go AS; Chiu VY; Schmitt SK; Ananth L; Frayne SM
    Am J Manag Care; 2011 Sep; 17(9):617-24. PubMed ID: 21902447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.